You are here

Outcomes of Spineology U.S. Clinical Trial for Interbody Fusion Shared at 2019 SMISS Meeting

ST. PAUL, Minn. November 2019 --( BUSINESS WIRE )-- Spineology Inc., an innovator in anatomy-conserving spine surgery, is pleased to announce that John Chi, M.D., MPH, Associate Professor of Neurosurgery at Harvard Medical School and the Director of Neurosurgical Spinal Oncology at Brigham and Women’s Hospital in Boston, Massachusetts, presented 24-month outcomes data from Spineology’s SCOUT clinical trial at last week’s Society for Minimally Invasive Spine Surgery (SMISS) Annual Meeting in Las Vegas, Nevada. The SCOUT study (Spineology Clinical Outcomes Trial), conducted under an FDA-approved IDE protocol, is a prospective, multi-center, non-randomized performance goal investigation designed to evaluate safety and...

Pages

Subscribe to Front page feed